Bill Text: TX SCR3 | 2023-2024 | 88th Legislature | Introduced
Bill Title: Expressing support for ending "gender-affirming care."
Sponsorship: Partisan Bill (Republican 2)
Status: (Introduced - Dead) 2023-02-15 - Referred to State Affairs [SCR3 Detail]
Download: Texas-2023-SCR3-Introduced.html
| 88R3473 BPG-D | ||
| By: Hall, Campbell | S.C.R. No. 3 | |
|
|
||
| WHEREAS, The American Academy of Pediatrics, American | ||
| Medical Association, and Children's Hospital Association wrote a | ||
| letter to the United States Attorney General on October 3, 2022, | ||
| requesting a Department of Justice investigation of organizations, | ||
| individuals, and entities that advocate against what they term | ||
| "gender-affirming health care"; and | ||
| WHEREAS, "Gender-affirming care" is an unconscionable | ||
| misnomer for the abhorrent practice of genital mutilation and the | ||
| administration of puberty blockers to children who can not even | ||
| legally smoke cigarettes; such "care" leads to irreparable harm, | ||
| psychological damage, and a lifetime of trauma; and | ||
| WHEREAS, The defenders of "gender-affirming" treatment wish | ||
| to silence the voices of those who have undergone gender | ||
| transitions and are left with immense, debilitating regret; they | ||
| ignore that other countries have examined the issue of whether | ||
| minors can adequately understand and properly consent to | ||
| "gender-affirming care"; in a landmark 2020 High Court decision in | ||
| the United Kingdom, the court ruled that the capacity to legally | ||
| consent to taking puberty blockers was "highly unlikely" for | ||
| 13-year-olds and "doubtful" for 14- and 15-year-olds; | ||
| consequently, the use of puberty blockers was suspended for | ||
| children under the age of 16; and | ||
| WHEREAS, In July 2022, the U.S. Food and Drug Administration | ||
| issued a warning regarding gonadotropin-releasing hormone | ||
| agonists, commonly known as puberty blockers; the FDA identified a | ||
| plausible association between GnRH agonist use and pseudotumor | ||
| cerebri, also known as idiopathic intracranial hypertension, which | ||
| occurs when pressure inside the skull spontaneously increases; the | ||
| condition can cause brain swelling, severe headaches, nausea, | ||
| double vision, and even permanent vision loss, according to the | ||
| Mayo Clinic; and | ||
| WHEREAS, "Gender-affirming care" is a dangerous practice | ||
| that destroys lives, and those who would suppress opposition to | ||
| such treatment are deserving of the harshest censure; now, | ||
| therefore, be it | ||
| RESOLVED, That the 88th Legislature of the State of Texas | ||
| hereby express support for ending "gender-affirming care" and | ||
| condemn the American Academy of Pediatrics, American Medical | ||
| Association, and Children's Hospital Association for their attempt | ||
| to suppress objections to such treatment. | ||
